Feedback / Questions
AVT23 (omalizumab biosimilar) - Kashiv Biosci, Alvotech, Advanz Pharma
https://www.globenewswire.com/news-release/2025/06/25/3104833/0/en/Positive-Top-Line-Results-from-Confirmatory-Efficacy-Study-for-Proposed-Biosimilar-to-Xolair-omalizumab.html
Jun 25, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next